ALX ONCOLOGY HOLDINGS INC
For the period ended Dec 31, 2023. Filed Mar 7, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Mar 7, 2024
ALXO$1.29+11.3%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Comprehensive Loss
(in thousands)
| Year Ended | |||
|---|---|---|---|
| December 31, | |||
| 2023 | 2022 | 2021 | |
| Net loss | $(160,805) | $(123,482) | $(83,463) |
| Other comprehensive gain (loss), net of tax: | |||
| Unrealized gain (loss) on available-for-sale investments | 1,101 | (845) | — |
| Total comprehensive loss | $(159,704) | $(124,327) | $(83,463) |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.